| https://www.novartis.com/ | 200 | NovartisPage checklist evidence- title: passedNovartis
- description: passedFor more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
- canonical: passedhttps://www.novartis.com/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 23 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 358 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedNovartis
- og-description: passedFor more than 250 years–and 30 years as Novartis–we’ve pursued scientific breakthroughs for one purpose: people. Today, we take on the toughest challenges in healthcare and turn innovations into medicines that redefine the future for patients.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10010 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed210,264 bytes of HTML; budget 500,000
| 1 | 733 |
| https://www.novartis.com/about | 200 | About | NovartisPage checklist evidence- title: passedAbout | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/about
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 28 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 17 buttons have no HTML name
- links-named: passed0 of 349 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAbout | Novartis
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11042 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed212,670 bytes of HTML; budget 500,000
| 1 | 176 |
| https://www.novartis.com/about/30-years-novartis-powered-250-years-innovation | 200 | 30 years of Novartis, powered by 250 years of innovation | NovartisPage checklist evidence- title: passed30 years of Novartis, powered by 250 years of innovation | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/about/30-years-novartis-powered-250-years-innovation
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 352 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/30-years-novartis-powered-250-years-innovation
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passed30 years of Novartis, powered by 250 years of innovation
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/30-years-novartis-powered-250-years-innovation
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10474 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed215,588 bytes of HTML; budget 500,000
| 1 | 213 |
| https://www.novartis.com/about/awards-and-recognition | 200 | Awards and recognition | NovartisPage checklist evidence- title: passedAwards and recognition | Novartis
- description: passedWe are honored to receive numerous awards for our work, culture and initiatives.
- canonical: passedhttps://www.novartis.com/about/awards-and-recognition
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 16 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 73 buttons have no HTML name
- links-named: passed0 of 403 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/awards-and-recognition
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAwards and recognition
- og-description: passedWe are honored to receive numerous awards for our work, culture and initiatives.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/awards-and-recognition
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed28500 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed274,149 bytes of HTML; budget 500,000
| 1 | 216 |
| https://www.novartis.com/about/board-directors | 200 | Board of Directors | NovartisPage checklist evidence- title: passedBoard of Directors | Novartis
- description: passedMeet the Novartis Board of Directors, responsible for the direction, strategy, and administration of this global pharmaceutical and biotech company.
- canonical: passedhttps://www.novartis.com/about/board-directors
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 27 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 358 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedBoard of Directors
- og-description: passedMeet the Novartis Board of Directors, responsible for the direction, strategy, and administration of this global pharmaceutical and biotech company.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9489 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed222,344 bytes of HTML; budget 500,000
| 1 | 190 |
| https://www.novartis.com/about/board-directors/ana-de-pro-gonzalo | 200 | Ana de Pro Gonzalo | NovartisPage checklist evidence- title: passedAna de Pro Gonzalo | Novartis
- description: passedBoard member since 2022
- canonical: passedhttps://www.novartis.com/about/board-directors/ana-de-pro-gonzalo
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/ana-de-pro-gonzalo
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAna de Pro Gonzalo
- og-description: passedBoard member since 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/ana-de-pro-gonzalo
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9932 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,123 bytes of HTML; budget 500,000
| 1 | 191 |
| https://www.novartis.com/about/board-directors/bridgette-heller | 200 | Bridgette Heller | NovartisPage checklist evidence- title: passedBridgette Heller | Novartis
- description: passedBoard member since February 28, 2020
- canonical: passedhttps://www.novartis.com/about/board-directors/bridgette-heller
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/bridgette-heller
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedBridgette Heller
- og-description: passedBoard member since February 28, 2020
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/bridgette-heller
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10946 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed200,242 bytes of HTML; budget 500,000
| 1 | 197 |
| https://www.novartis.com/about/board-directors/charles-swanton | 200 | Charles Swanton | NovartisPage checklist evidence- title: passedCharles Swanton | Novartis
- description: passedCharles Swanton is a British clinician, scientist and medical oncologist with experience in board governance, large-scale program leadership, and translational R&D.
- canonical: passedhttps://www.novartis.com/about/board-directors/charles-swanton
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/charles-swanton
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCharles Swanton
- og-description: passedCharles Swanton is a British clinician, scientist and medical oncologist with experience in board governance, large-scale program leadership, and translational R&D.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/charles-swanton
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9883 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,542 bytes of HTML; budget 500,000
| 1 | 192 |
| https://www.novartis.com/about/board-directors/charlotte-pamer-wieser | 200 | Charlotte Pamer-Wieser | NovartisPage checklist evidence- title: passedCharlotte Pamer-Wieser | Novartis
- description: passedCorporate Secretary since 2011
- canonical: passedhttps://www.novartis.com/about/board-directors/charlotte-pamer-wieser
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/charlotte-pamer-wieser
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCharlotte Pamer-Wieser
- og-description: passedCorporate Secretary since 2011
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/charlotte-pamer-wieser
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9111 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed198,469 bytes of HTML; budget 500,000
| 1 | 177 |
| https://www.novartis.com/about/board-directors/elizabeth-liz-doherty | 200 | Elizabeth (Liz) Doherty | NovartisPage checklist evidence- title: passedElizabeth (Liz) Doherty | Novartis
- description: passedBoard member since 2016
- canonical: passedhttps://www.novartis.com/about/board-directors/elizabeth-liz-doherty
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/elizabeth-liz-doherty
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedElizabeth (Liz) Doherty
- og-description: passedBoard member since 2016
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/elizabeth-liz-doherty
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10077 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,399 bytes of HTML; budget 500,000
| 1 | 192 |
| https://www.novartis.com/about/board-directors/elizabeth-mcnally | 200 | Elizabeth McNally | NovartisPage checklist evidence- title: passedElizabeth McNally | Novartis
- description: passedBoard member since 2025
- canonical: passedhttps://www.novartis.com/about/board-directors/elizabeth-mcnally
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/elizabeth-mcnally
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedElizabeth McNally
- og-description: passedBoard member since 2025
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/elizabeth-mcnally
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10429 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,625 bytes of HTML; budget 500,000
| 1 | 188 |
| https://www.novartis.com/about/board-directors/frans-van-houten | 200 | Frans van Houten | NovartisPage checklist evidence- title: passedFrans van Houten | Novartis
- description: passedBoard member since 2017
- canonical: passedhttps://www.novartis.com/about/board-directors/frans-van-houten
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/frans-van-houten
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedFrans van Houten
- og-description: passedBoard member since 2017
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/frans-van-houten
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10380 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,496 bytes of HTML; budget 500,000
| 1 | 229 |
| https://www.novartis.com/about/board-directors/giovanni-caforio | 200 | Giovanni Caforio | NovartisPage checklist evidence- title: passedGiovanni Caforio | Novartis
- description: passedChair since 2025
- canonical: passedhttps://www.novartis.com/about/board-directors/giovanni-caforio
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/giovanni-caforio
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedGiovanni Caforio
- og-description: passedChair since 2025
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/giovanni-caforio
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9977 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,084 bytes of HTML; budget 500,000
| 1 | 174 |
| https://www.novartis.com/about/board-directors/john-d-young | 200 | John D. Young | NovartisPage checklist evidence- title: passedJohn D. Young | Novartis
- description: passedBoard member since March 2023
- canonical: passedhttps://www.novartis.com/about/board-directors/john-d-young
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/john-d-young
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedJohn D. Young
- og-description: passedBoard member since March 2023
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/john-d-young
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10641 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,948 bytes of HTML; budget 500,000
| 1 | 176 |
| https://www.novartis.com/about/board-directors/nancy-c-andrews | 200 | Nancy C. Andrews | NovartisPage checklist evidence- title: passedNancy C. Andrews | Novartis
- description: passedBoard member since 2015
- canonical: passedhttps://www.novartis.com/about/board-directors/nancy-c-andrews
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/nancy-c-andrews
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedNancy C. Andrews
- og-description: passedBoard member since 2015
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/nancy-c-andrews
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10687 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,914 bytes of HTML; budget 500,000
| 1 | 168 |
| https://www.novartis.com/about/board-directors/patrice-bula | 200 | Patrice Bula | NovartisPage checklist evidence- title: passedPatrice Bula | Novartis
- description: passedBoard member since 2019 | Lead Independent Director since March 4, 2022
- canonical: passedhttps://www.novartis.com/about/board-directors/patrice-bula
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/patrice-bula
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedPatrice Bula
- og-description: passedBoard member since 2019 | Lead Independent Director since March 4, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/patrice-bula
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10407 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,608 bytes of HTML; budget 500,000
| 1 | 227 |
| https://www.novartis.com/about/board-directors/simon-moroney | 200 | Simon Moroney | NovartisPage checklist evidence- title: passedSimon Moroney | Novartis
- description: passedBoard member since February 28, 2020 | Vice Chair since March 4, 2022
- canonical: passedhttps://www.novartis.com/about/board-directors/simon-moroney
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/simon-moroney
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedSimon Moroney
- og-description: passedBoard member since February 28, 2020 | Vice Chair since March 4, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/simon-moroney
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9522 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed198,727 bytes of HTML; budget 500,000
| 1 | 174 |
| https://www.novartis.com/about/board-directors/ton-buechner | 200 | Ton Buechner | NovartisPage checklist evidence- title: passedTon Buechner | Novartis
- description: passedBoard member since 2016
- canonical: passedhttps://www.novartis.com/about/board-directors/ton-buechner
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/board-directors/ton-buechner
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedTon Buechner
- og-description: passedBoard member since 2016
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/board-directors/ton-buechner
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10135 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,094 bytes of HTML; budget 500,000
| 1 | 179 |
| https://www.novartis.com/about/executive-committee | 200 | Executive Committee | NovartisPage checklist evidence- title: passedExecutive Committee | Novartis
- description: passedUnder the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.
- canonical: passedhttps://www.novartis.com/about/executive-committee
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 27 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed4 of 363 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedExecutive Committee
- og-description: passedUnder the leadership of Vasant Narasimhan, the Executive Committee of Novartis (ECN) is responsible for overseeing the company's business operations.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9509 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed225,082 bytes of HTML; budget 500,000
| 1 | 193 |
| https://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd | 200 | Aharon (Ronny) Gal, Ph.D. | NovartisPage checklist evidence- title: passedAharon (Ronny) Gal, Ph.D. | Novartis
- description: passedMember of the Executive Committee, Chief Strategy & Growth Officer since July 18, 2022
- canonical: passedhttps://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAharon (Ronny) Gal, Ph.D.
- og-description: passedMember of the Executive Committee, Chief Strategy & Growth Officer since July 18, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/aharon-ronny-gal-phd
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10902 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,434 bytes of HTML; budget 500,000
| 1 | 198 |
| https://www.novartis.com/about/executive-committee/fiona-marshall | 200 | Fiona Marshall | NovartisPage checklist evidence- title: passedFiona Marshall | Novartis
- description: passedPresident, Biomedical Research since November 1, 2022
- canonical: passedhttps://www.novartis.com/about/executive-committee/fiona-marshall
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/fiona-marshall
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedFiona Marshall
- og-description: passedPresident, Biomedical Research since November 1, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/fiona-marshall
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11529 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,703 bytes of HTML; budget 500,000
| 1 | 186 |
| https://www.novartis.com/about/executive-committee/karen-hale | 200 | Karen Hale | NovartisPage checklist evidence- title: passedKaren Hale | Novartis
- description: passedIn her role as Chief Legal Officer of Novartis, Karen Hale will lead a global legal and public affairs function that supports the company’s purpose of reimagining medicine while ensuring high standards of ethics and business conduct to reinforce trust with soc
- canonical: passedhttps://www.novartis.com/about/executive-committee/karen-hale
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/karen-hale
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedKaren Hale
- og-description: passedIn her role as Chief Legal Officer of Novartis, Karen Hale will lead a global legal and public affairs function that supports the company’s purpose of reimagining medicine while ensuring high standards of ethics and business conduct to reinforce trust with soc
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/karen-hale
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10798 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,350 bytes of HTML; budget 500,000
| 1 | 226 |
| https://www.novartis.com/about/executive-committee/lutz-hegemann | 200 | Lutz Hegemann | NovartisPage checklist evidence- title: passedLutz Hegemann | Novartis
- description: passedAs President, Global Health & Sustainability, Lutz Hegemann is responsible for integrating global health and environmental, social and governance (ESG) matters into the core of the Novartis business.
- canonical: passedhttps://www.novartis.com/about/executive-committee/lutz-hegemann
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 349 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/lutz-hegemann
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedLutz Hegemann
- og-description: passedAs President, Global Health & Sustainability, Lutz Hegemann is responsible for integrating global health and environmental, social and governance (ESG) matters into the core of the Novartis business.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/lutz-hegemann
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10148 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed202,133 bytes of HTML; budget 500,000
| 1 | 179 |
| https://www.novartis.com/about/executive-committee/michelle-weese | 200 | Michelle Weese | NovartisPage checklist evidence- title: passedMichelle Weese | Novartis
- description: passedMichelle Weese is Head of Corporate Affairs for Novartis, leading a function that brings together the company’s Global Public and Government Affairs, Communications & Engagement (including Patient Engagement), and Global Heath & Sustainability teams.
- canonical: passedhttps://www.novartis.com/about/executive-committee/michelle-weese
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/michelle-weese
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedMichelle Weese
- og-description: passedMichelle Weese is Head of Corporate Affairs for Novartis, leading a function that brings together the company’s Global Public and Government Affairs, Communications & Engagement (including Patient Engagement), and Global Heath & Sustainability teams.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/michelle-weese
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10697 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed202,189 bytes of HTML; budget 500,000
| 1 | 190 |
| https://www.novartis.com/about/executive-committee/mukul-mehta | 200 | Mukul Mehta | NovartisPage checklist evidence- title: passedMukul Mehta | Novartis
- description: passedMukul Mehta was appointed Chief Financial Officer of Novartis on March 16, 2026
- canonical: passedhttps://www.novartis.com/about/executive-committee/mukul-mehta
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 349 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/mukul-mehta
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedMukul Mehta
- og-description: passedMukul Mehta was appointed Chief Financial Officer of Novartis on March 16, 2026
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/mukul-mehta
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11532 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed202,541 bytes of HTML; budget 500,000
| 1 | 194 |
| https://www.novartis.com/about/executive-committee/patrick-horber-md | 200 | Patrick Horber, M.D. | NovartisPage checklist evidence- title: passedPatrick Horber, M.D. | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/about/executive-committee/patrick-horber-md
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/patrick-horber-md
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedPatrick Horber, M.D.
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/patrick-horber-md
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11881 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,633 bytes of HTML; budget 500,000
| 1 | 197 |
| https://www.novartis.com/about/executive-committee/rob-kowalski | 200 | Rob Kowalski | NovartisPage checklist evidence- title: passedRob Kowalski | Novartis
- description: passedAs Chief People & Organization (P&O) Officer of Novartis, Rob Kowalski leads the company’s strategy to unleash the power of its more than 100,000 employees to support its long-term priorities and purpose.
- canonical: passedhttps://www.novartis.com/about/executive-committee/rob-kowalski
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/rob-kowalski
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedRob Kowalski
- og-description: passedAs Chief People & Organization (P&O) Officer of Novartis, Rob Kowalski leads the company’s strategy to unleash the power of its more than 100,000 employees to support its long-term priorities and purpose.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/rob-kowalski
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11919 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed204,562 bytes of HTML; budget 500,000
| 1 | 223 |
| https://www.novartis.com/about/executive-committee/shreeram-aradhye | 200 | Shreeram Aradhye | NovartisPage checklist evidence- title: passedShreeram Aradhye | Novartis
- description: passedPresident, Development and Chief Medical Officer since May 16, 2022
- canonical: passedhttps://www.novartis.com/about/executive-committee/shreeram-aradhye
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 351 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/shreeram-aradhye
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedShreeram Aradhye
- og-description: passedPresident, Development and Chief Medical Officer since May 16, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/shreeram-aradhye
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12363 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed205,398 bytes of HTML; budget 500,000
| 1 | 179 |
| https://www.novartis.com/about/executive-committee/steffen-lang | 200 | Steffen Lang | NovartisPage checklist evidence- title: passedSteffen Lang | Novartis
- description: passedPresident, Operations, since April 4, 2022
- canonical: passedhttps://www.novartis.com/about/executive-committee/steffen-lang
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed2 of 352 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/steffen-lang
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedSteffen Lang
- og-description: passedPresident, Operations, since April 4, 2022
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/steffen-lang
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11573 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed204,501 bytes of HTML; budget 500,000
| 1 | 314 |
| https://www.novartis.com/about/executive-committee/teresa-jose | 200 | Teresa Jose | NovartisPage checklist evidence- title: passedTeresa Jose | Novartis
- description: passedChief Audit Officer since July 1, 2025
- canonical: passedhttps://www.novartis.com/about/executive-committee/teresa-jose
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/teresa-jose
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedTeresa Jose
- og-description: passedChief Audit Officer since July 1, 2025
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/teresa-jose
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10241 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed200,262 bytes of HTML; budget 500,000
| 1 | 264 |
| https://www.novartis.com/about/executive-committee/vasant-narasimhan | 200 | Vasant Narasimhan | NovartisPage checklist evidence- title: passedVasant Narasimhan | Novartis
- description: passedVasant (Vas) Narasimhan, M.D., has been Chief Executive Officer (CEO) of Novartis since February 1, 2018.
- canonical: passedhttps://www.novartis.com/about/executive-committee/vasant-narasimhan
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed3 of 353 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/vasant-narasimhan
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedVasant Narasimhan
- og-description: passedVasant (Vas) Narasimhan, M.D., has been Chief Executive Officer (CEO) of Novartis since February 1, 2018.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/vasant-narasimhan
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12941 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed206,536 bytes of HTML; budget 500,000
| 1 | 199 |
| https://www.novartis.com/about/executive-committee/victor-bulto | 200 | Victor Bulto | NovartisPage checklist evidence- title: passedVictor Bulto | Novartis
- description: passedAs President of the Innovative Medicines US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.
- canonical: passedhttps://www.novartis.com/about/executive-committee/victor-bulto
- h1: passed1 H1 element(s)
- headings: failed2 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 351 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/executive-committee/victor-bulto
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedVictor Bulto
- og-description: passedAs President of the Innovative Medicines US unit for Novartis, Victor Bulto is pursuing a bold strategy to reimagine medicine and deliver on the company’s responsibility to unlock the potential for helping patients in the world’s largest healthcare market.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/executive-committee/victor-bulto
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/styles/biography_page_image/public/2022-04/victor-bulto.jpg
- og-alt: passedVictor Bulto,President, Innovative Medicines US since April 4, 2022
- twitter-card: passedsummary_large_image
- readable: passed11886 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed206,437 bytes of HTML; budget 500,000
| 1 | 185 |
| https://www.novartis.com/about/inclusion | 200 | Inclusion | NovartisPage checklist evidence- title: passedInclusion | Novartis
- description: passedWe want to build a diverse and inclusive workplace where every one of us can be our best and true selves, so that together we can discover more, reach underserved communities and reimagine medicine. Learn more about our commitments to diversity and inclusion,
- canonical: passedhttps://www.novartis.com/about/inclusion
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 25 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 356 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/inclusion
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedInclusion | Novartis
- og-description: passedWe want to build a diverse and inclusive workplace where every one of us can be our best and true selves, so that together we can discover more, reach underserved communities and reimagine medicine. Learn more about our commitments to diversity and inclusion,
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/inclusion
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11097 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed218,543 bytes of HTML; budget 500,000
| 1 | 229 |
| https://www.novartis.com/about/inclusion/building-belonging | 200 | Building belonging | NovartisPage checklist evidence- title: passedBuilding belonging | Novartis
- description: passedWe’re building a culture that stimulates curiosity and promotes opportunities to learn from and embrace all of our diverse perspectives.
- canonical: passedhttps://www.novartis.com/about/inclusion/building-belonging
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 15 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 346 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/inclusion/building-belonging
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedBuilding belonging
- og-description: passedWe’re building a culture that stimulates curiosity and promotes opportunities to learn from and embrace all of our diverse perspectives.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/inclusion/building-belonging
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9883 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed201,724 bytes of HTML; budget 500,000
| 1 | 234 |
| https://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people | 200 | Caring for the mental health and wellbeing of our people | NovartisPage checklist evidence- title: passedCaring for the mental health and wellbeing of our people | Novartis
- description: passedThe mental health and wellbeing of our people is vitally important. It is a natural extension of our company’s purpose to discover new ways to improve and extend people’s lives. Our ambition at Novartis is to always take outstanding care of our people so that
- canonical: passedhttps://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 361 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCaring for the mental health and wellbeing of our people
- og-description: passedThe mental health and wellbeing of our people is vitally important. It is a natural extension of our company’s purpose to discover new ways to improve and extend people’s lives. Our ambition at Novartis is to always take outstanding care of our people so that
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/inclusion/caring-mental-health-and-wellbeing-our-people
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed19020 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed227,298 bytes of HTML; budget 500,000
| 1 | 178 |
| https://www.novartis.com/about/inclusion/parental-leave | 200 | Parental leave | NovartisPage checklist evidence- title: passedParental leave | Novartis
- description: passedAt Novartis, we celebrate life and recognize moments that matter. From January 2021, all Novartis associates will be able to benefit from a minimum
- canonical: passedhttps://www.novartis.com/about/inclusion/parental-leave
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 345 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/inclusion/parental-leave
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedParental leave
- og-description: passedAt Novartis, we celebrate life and recognize moments that matter. From January 2021, all Novartis associates will be able to benefit from a minimum
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/inclusion/parental-leave
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9225 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed196,672 bytes of HTML; budget 500,000
| 1 | 211 |
| https://www.novartis.com/about/inclusion/promoting-inclusion | 200 | Promoting inclusion | NovartisPage checklist evidence- title: passedPromoting inclusion | Novartis
- description: passedAt Novartis, we’re striving to build an inclusive and equitable workplace that empowers all of our associates to achieve their full potential.
- canonical: passedhttps://www.novartis.com/about/inclusion/promoting-inclusion
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 15 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 360 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/inclusion/promoting-inclusion
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedPromoting inclusion
- og-description: passedAt Novartis, we’re striving to build an inclusive and equitable workplace that empowers all of our associates to achieve their full potential.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/inclusion/promoting-inclusion
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11007 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed221,029 bytes of HTML; budget 500,000
| 1 | 221 |
| https://www.novartis.com/about/locations | 200 | Locations | NovartisPage checklist evidence- title: passedLocations | Novartis
- description: passedFind information on our research locations and corporate offices around the world.
- canonical: passedhttps://www.novartis.com/about/locations
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: failed2 of 4 controls have no HTML label
- buttons: passed0 of 17 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/locations
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedLocations | Novartis
- og-description: passedFind information on our research locations and corporate offices around the world.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/locations
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11024 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed213,123 bytes of HTML; budget 500,000
| 1 | 233 |
| https://www.novartis.com/about/manufacturing | 200 | Manufacturing | NovartisPage checklist evidence- title: passedManufacturing | Novartis
- description: passedNovartis operates in more than 30 production sites worldwide. Our sites are fully focused on producing innovative medicines across our priority technology platforms.
- canonical: passedhttps://www.novartis.com/about/manufacturing
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 357 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/manufacturing
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedManufacturing | Novartis
- og-description: passedNovartis operates in more than 30 production sites worldwide. Our sites are fully focused on producing innovative medicines across our priority technology platforms.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/manufacturing
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11676 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed211,617 bytes of HTML; budget 500,000
| 1 | 254 |
| https://www.novartis.com/about/novartis-gene-therapies | 200 | Novartis Gene Therapies | NovartisPage checklist evidence- title: passedNovartis Gene Therapies | Novartis
- description: passedLearn what cell and gene therapy is, how it differs from conventional medicine, and why it's creating a new turning point in how we treat disease.
- canonical: passedhttps://www.novartis.com/about/novartis-gene-therapies
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 356 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/novartis-gene-therapies
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedNovartis Gene Therapies | Novartis
- og-description: passedLearn what cell and gene therapy is, how it differs from conventional medicine, and why it's creating a new turning point in how we treat disease.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/novartis-gene-therapies
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10376 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed204,187 bytes of HTML; budget 500,000
| 1 | 193 |
| https://www.novartis.com/about/people-and-culture | 200 | People and culture | NovartisPage checklist evidence- title: passedPeople and culture | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/about/people-and-culture
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 28 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 352 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/people-and-culture
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedPeople and culture | Novartis
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/people-and-culture
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10726 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed226,415 bytes of HTML; budget 500,000
| 1 | 183 |
| https://www.novartis.com/about/products | 200 | Products | NovartisPage checklist evidence- title: passedProducts | Novartis
- description: passedDiscover the diverse and innovative Novartis Global Product Portfolio and find information about each pharmaceutical treatment.
- canonical: passedhttps://www.novartis.com/about/products
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: failed1 of 3 controls have no HTML label
- buttons: passed0 of 14 buttons have no HTML name
- links-named: passed0 of 408 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/products
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedProducts | Novartis
- og-description: passedDiscover the diverse and innovative Novartis Global Product Portfolio and find information about each pharmaceutical treatment.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/products
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9638 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed211,431 bytes of HTML; budget 500,000
| 1 | 209 |
| https://www.novartis.com/about/quality | 200 | Quality | NovartisPage checklist evidence- title: passedQuality | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/about/quality
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedQuality | Novartis
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10268 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed196,955 bytes of HTML; budget 500,000
| 1 | 191 |
| https://www.novartis.com/about/quality/audit-program-and-regulatory-inspections | 200 | Audit program and regulatory inspections | NovartisPage checklist evidence- title: passedAudit program and regulatory inspections | Novartis
- description: passedAudit program and regulatory inspections
- canonical: passedhttps://www.novartis.com/about/quality/audit-program-and-regulatory-inspections
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality/audit-program-and-regulatory-inspections
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAudit program and regulatory inspections
- og-description: passedAudit program and regulatory inspections
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality/audit-program-and-regulatory-inspections
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10323 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed196,304 bytes of HTML; budget 500,000
| 1 | 225 |
| https://www.novartis.com/about/quality/novartis-quality-management-system-qms | 200 | Novartis quality management system (QMS) | NovartisPage checklist evidence- title: passedNovartis quality management system (QMS) | Novartis
- description: passedNovartis Quality Management System (QMS)
- canonical: passedhttps://www.novartis.com/about/quality/novartis-quality-management-system-qms
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality/novartis-quality-management-system-qms
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedNovartis quality management system (QMS)
- og-description: passedNovartis Quality Management System (QMS)
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality/novartis-quality-management-system-qms
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12877 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed199,061 bytes of HTML; budget 500,000
| 1 | 212 |
| https://www.novartis.com/about/quality/product-and-patient-safety-training | 200 | Product and patient safety training | NovartisPage checklist evidence- title: passedProduct and patient safety training | Novartis
- description: passedWe have a very robust quality and safety training process (initial and continuous training) for our associates and we are regularly audited on our training procedures.
- canonical: passedhttps://www.novartis.com/about/quality/product-and-patient-safety-training
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 345 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality/product-and-patient-safety-training
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedProduct and patient safety training
- og-description: passedWe have a very robust quality and safety training process (initial and continuous training) for our associates and we are regularly audited on our training procedures.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality/product-and-patient-safety-training
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10560 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed195,902 bytes of HTML; budget 500,000
| 1 | 185 |
| https://www.novartis.com/about/quality/product-recalls | 200 | Product recalls | NovartisPage checklist evidence- title: passedProduct recalls | Novartis
- description: passedNovartis maintains a comprehensive process across the entire company to assess quality defects and safety issues and whether a market action (such as a product recall) would be required.
- canonical: passedhttps://www.novartis.com/about/quality/product-recalls
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality/product-recalls
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedProduct recalls
- og-description: passedNovartis maintains a comprehensive process across the entire company to assess quality defects and safety issues and whether a market action (such as a product recall) would be required.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality/product-recalls
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9356 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed195,847 bytes of HTML; budget 500,000
| 1 | 219 |
| https://www.novartis.com/about/quality/third-party-suppliers | 200 | Third-party suppliers | NovartisPage checklist evidence- title: passedThird-party suppliers | Novartis
- description: passedIn accordance with health authority requirements and expectations, all third parties with whom Novartis does business, and who provide goods or services that fall within the scope of GxP, including Good Manufacturing Practice (GMP) or Good Distribution Practic
- canonical: passedhttps://www.novartis.com/about/quality/third-party-suppliers
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/quality/third-party-suppliers
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedThird-party suppliers
- og-description: passedIn accordance with health authority requirements and expectations, all third parties with whom Novartis does business, and who provide goods or services that fall within the scope of GxP, including Good Manufacturing Practice (GMP) or Good Distribution Practic
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/quality/third-party-suppliers
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10912 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed197,675 bytes of HTML; budget 500,000
| 1 | 202 |
| https://www.novartis.com/about/therapeutic-areas | 200 | Therapeutic areas | NovartisPage checklist evidence- title: passedTherapeutic areas | Novartis
- description: passedOur innovative medicines strike the balance between bold science and a deep understanding of the human experience of disease.
- canonical: passedhttps://www.novartis.com/about/therapeutic-areas
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 349 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/therapeutic-areas
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedTherapeutic areas | Novartis
- og-description: passedOur innovative medicines strike the balance between bold science and a deep understanding of the human experience of disease.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/therapeutic-areas
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10627 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed217,931 bytes of HTML; budget 500,000
| 1 | 180 |
| https://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic | 200 | Cardiovascular, renal and metabolic | NovartisPage checklist evidence- title: passedCardiovascular, renal and metabolic | Novartis
- description: passedTransforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD), the world’s biggest killer, and ease the burden for peopl
- canonical: passedhttps://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 375 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCardiovascular, renal and metabolic
- og-description: passedTransforming the treatment and healthcare system landscape using early interventions, pioneering treatments, and innovative partnerships to avoid preventable mortality from cardiovascular disease (CVD), the world’s biggest killer, and ease the burden for peopl
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/therapeutic-areas/cardiovascular-renal-and-metabolic
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed16472 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed224,359 bytes of HTML; budget 500,000
| 1 | 211 |
| https://www.novartis.com/about/therapeutic-areas/immunology | 200 | Immunology | NovartisPage checklist evidence- title: passedImmunology | Novartis
- description: passedWorking to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
- canonical: passedhttps://www.novartis.com/about/therapeutic-areas/immunology
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 24 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 376 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/therapeutic-areas/immunology
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedImmunology
- og-description: passedWorking to create a world where the millions of people with immunological conditions, and those who treat them, can live without compromise.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/therapeutic-areas/immunology
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed14436 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed223,004 bytes of HTML; budget 500,000
| 1 | 215 |
| https://www.novartis.com/about/therapeutic-areas/neuroscience | 200 | Neuroscience | NovartisPage checklist evidence- title: passedNeuroscience | Novartis
- description: passedCreating a transformational impact for people living with severe neurological conditions and their caregivers by discovering, developing and delivering innovative that change the course of disease progression.Our ambition is to createCreating a transformationa
- canonical: passedhttps://www.novartis.com/about/therapeutic-areas/neuroscience
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 367 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/therapeutic-areas/neuroscience
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedNeuroscience
- og-description: passedCreating a transformational impact for people living with severe neurological conditions and their caregivers by discovering, developing and delivering innovative that change the course of disease progression.Our ambition is to createCreating a transformationa
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/therapeutic-areas/neuroscience
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed13072 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed223,991 bytes of HTML; budget 500,000
| 1 | 233 |
| https://www.novartis.com/about/therapeutic-areas/oncology | 200 | Oncology | NovartisPage checklist evidence- title: passedOncology | Novartis
- description: passedCombining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.
- canonical: passedhttps://www.novartis.com/about/therapeutic-areas/oncology
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 24 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 389 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/about/therapeutic-areas/oncology
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedOncology
- og-description: passedCombining the power of science and empathy to unravel the inner workings of cancer and develop innovative therapies that restore hope to those with cancer and their loved ones.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/about/therapeutic-areas/oncology
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed15197 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed228,764 bytes of HTML; budget 500,000
| 1 | 220 |
| https://www.novartis.com/acc-es/ | 200 | Novartis ACCPage checklist evidence- title: passedNovartis ACC
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/acc-es/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedes
- alt: passed0 of 17 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 197 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/acc-es/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/acc-es/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5841 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed116,873 bytes of HTML; budget 500,000
| 1 | 181 |
| https://www.novartis.com/accessibility | 200 | Web Accessibility | NovartisPage checklist evidence- title: passedWeb Accessibility | Novartis
- description: passedNovartis is committed to improving the accessibility and useability of our websites, ensuring that content and services are available to all visitors, regardless of their ability or the technology they are using.
- canonical: passedhttps://www.novartis.com/accessibility
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 8 controls have no HTML label
- buttons: passed0 of 14 buttons have no HTML name
- links-named: passed0 of 346 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/accessibility
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedWeb Accessibility
- og-description: passedNovartis is committed to improving the accessibility and useability of our websites, ensuring that content and services are available to all visitors, regardless of their ability or the technology they are using.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/accessibility
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9579 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed198,640 bytes of HTML; budget 500,000
| 1 | 197 |
| https://www.novartis.com/al-en/ | 200 | Novartis AlbaniaPage checklist evidence- title: passedNovartis Albania
- description: passedNovartis Albania is reimagining medicine by delivering innovative treatments, advancing research and development, supporting patients and caregivers, and partnering with healthcare professionals to improve lives.
- canonical: passedhttps://www.novartis.com/al-en/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 22 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 197 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/al-en/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis Albania is reimagining medicine by delivering innovative treatments, advancing research and development, supporting patients and caregivers, and partnering with healthcare professionals to improve lives.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/al-en/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4889 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed114,195 bytes of HTML; budget 500,000
| 1 | 517 |
| https://www.novartis.com/al-sq/ | 200 | Novartis ShqipëriPage checklist evidence- title: passedNovartis Shqipëri
- description: passedNovartis Albania po riformëson mjekësinë duke ofruar trajtime inovative, duke avancuar kërkimin dhe zhvillimin, duke mbështetur pacientët dhe kujdestarët, si dhe duke bashkëpunuar me profesionistët e shëndetësisë për të përmirësuar jetën.
- canonical: passedhttps://www.novartis.com/al-sq/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedsq
- alt: passed0 of 22 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 197 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/al-sq/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedFaqja Kryesore
- og-description: passedNovartis Albania po riformëson mjekësinë duke ofruar trajtime inovative, duke avancuar kërkimin dhe zhvillimin, duke mbështetur pacientët dhe kujdestarët, si dhe duke bashkëpunuar me profesionistët e shëndetësisë për të përmirësuar jetën.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/al-sq/faqja-kryesore
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5378 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed116,335 bytes of HTML; budget 500,000
| 1 | 197 |
| https://www.novartis.com/ar-es/ | 200 | Novartis Argentina S.A.Page checklist evidence- title: passedNovartis Argentina S.A.
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/ar-es/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedes
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 12 buttons have no HTML name
- links-named: passed0 of 186 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ar-es/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedInicio
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ar-es/inicio
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4930 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed107,133 bytes of HTML; budget 500,000
| 1 | 164 |
| https://www.novartis.com/at-de/ | 200 | Home | Novartis ÖsterreichPage checklist evidence- title: passedHome | Novartis Österreich
- description: passedWillkommen auf der offiziellen Website von Novartis Österreich. Entdecken Sie innovative Therapien, Forschung, Karriere und aktuelle Neuigkeiten.
- canonical: passedhttps://www.novartis.com/at-de/
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedde
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 245 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/at-de/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedStartseite
- og-description: passedNovartis Österreich - bei Novartis denken wir Medizin neu. Wir wollen neue Wege finden, um Menschen zu einem besseren und längeren Leben zu verhelfen.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/at-de/startseite
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis Logo
- twitter-card: passedsummary_large_image
- readable: passed6344 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed147,691 bytes of HTML; budget 500,000
| 1 | 206 |
| https://www.novartis.com/au-en/ | 200 | Novartis AustraliaPage checklist evidence- title: passedNovartis Australia
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/au-en/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 217 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/au-en/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/au-en/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5430 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed123,867 bytes of HTML; budget 500,000
| 1 | 191 |
| https://www.novartis.com/be-fr/ | 200 | Novartis BelgiumPage checklist evidence- title: passedNovartis Belgium
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/be-fr/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedfr
- alt: passed0 of 26 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 225 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/be-fr/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAccueil
- og-description: passedNovartis Belgium as a healthcare pioneer began more than 100 years ago in 1920 when Ciba was founded. Novartis in Belgium, with headquarters in Vilvoorde is a leading company for innovative medicines that improve the health maintain and improve well-being, wit
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/be-fr/accueil
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed6274 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed142,913 bytes of HTML; budget 500,000
| 1 | 683 |
| https://www.novartis.com/be-nl/ | 200 | Novartis BelgiumPage checklist evidence- title: passedNovartis Belgium
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/be-nl/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passednl
- alt: passed0 of 26 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 225 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/be-nl/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis Belgium as a healthcare pioneer began more than 100 years ago in 1920 when Ciba was founded. Novartis in Belgium, with headquarters in Vilvoorde is a leading company for innovative medicines that improve the health maintain and improve well-being, wit
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/be-nl/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5852 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed141,643 bytes of HTML; budget 500,000
| 1 | 182 |
| https://www.novartis.com/bg-bg/ | 200 | Новартис БългарияPage checklist evidence- title: passedНовартис България
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/bg-bg/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedbg
- alt: passed0 of 27 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 212 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/bg-bg/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedНачало
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Новартис е световна компания, посветена на здравеопазването. Тя е базирана в Швейцария и дава решения, които адресират ево
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/bg-bg/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed7239 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed137,483 bytes of HTML; budget 500,000
| 1 | 217 |
| https://www.novartis.com/br-pt/ | 200 | Novartis BrasilPage checklist evidence- title: passedNovartis Brasil
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/br-pt/
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedpt-br
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 200 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/br-pt/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedPágina Inicial
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis hoje concentra seus esforços em inovação para as necessidades não atendidas de pacientes no mundo todo.A Novartis
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/br-pt/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4874 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed115,860 bytes of HTML; budget 500,000
| 1 | 161 |
| https://www.novartis.com/ca-en/ | 200 | Novartis CanadaPage checklist evidence- title: passedNovartis Canada
- description: passedAt Novartis, we are reimagining medicine
- canonical: passedhttps://www.novartis.com/ca-en/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 221 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ca-en/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedAt Novartis, we are reimagining medicine Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and marketing of innovative products to improve the well-being of all Canadians. Located in Dorval, Queb
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ca-en/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5653 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed127,652 bytes of HTML; budget 500,000
| 1 | 194 |
| https://www.novartis.com/ca-fr/ | 200 | Novartis CanadaPage checklist evidence- title: passedNovartis Canada
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/ca-fr/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedfr
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 222 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ca-fr/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis Pharmaceuticals Canada Inc., a leader in the healthcare field, is committed to the discovery, development and mar
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ca-fr/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed6214 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed129,980 bytes of HTML; budget 500,000
| 1 | 517 |
| https://www.novartis.com/careers | 200 | Careers | NovartisPage checklist evidence- title: passedCareers | Novartis
- description: passedSearch for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life.
- canonical: passedhttps://www.novartis.com/careers
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 47 images lack an alt attribute
- labels: passed0 of 7 controls have no HTML label
- buttons: passed0 of 18 buttons have no HTML name
- links-named: passed0 of 383 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareers
- og-description: passedSearch for careers at Novartis and discover our diverse and inclusive teams where we collaborate to bring innovative products to life.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed17409 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed267,542 bytes of HTML; budget 500,000
| 1 | 179 |
| https://www.novartis.com/careers/career-hub | 200 | Career hub | NovartisPage checklist evidence- title: passedCareer hub | Novartis
- description: passedHints, tips and insights to help with your application
- canonical: passedhttps://www.novartis.com/careers/career-hub
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 23 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/career-hub
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareer hub | Novartis
- og-description: passedHints, tips and insights to help with your application
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/career-hub
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10218 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed207,606 bytes of HTML; budget 500,000
| 1 | 217 |
| https://www.novartis.com/careers/career-search | 200 | Career Search | NovartisPage checklist evidence- title: passedCareer Search | Novartis
- description: passedExplore opportunities with Novartis below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
- canonical: passedhttps://www.novartis.com/careers/career-search
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 7 controls have no HTML label
- buttons: passed0 of 14 buttons have no HTML name
- links-named: passed0 of 376 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/career-search
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareer Search | Novartis
- og-description: passedExplore opportunities with Novartis below. For additional roles with Novartis Gene Therapies (formerly AveXis) visit the GTx Career Search.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/career-search
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12238 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed213,755 bytes of HTML; budget 500,000
| 1 | 177 |
| https://www.novartis.com/careers/early-careers | 200 | Early careers | NovartisPage checklist evidence- title: passedEarly careers | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/careers/early-careers
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 25 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 356 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/early-careers
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedEarly careers
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/early-careers
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12055 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed229,269 bytes of HTML; budget 500,000
| 1 | 220 |
| https://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell | 200 | Community exploration and learning lab (CELL) | NovartisPage checklist evidence- title: passedCommunity exploration and learning lab (CELL) | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 15 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 16 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCommunity exploration and learning lab (CELL)
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/early-careers/community-exploration-and-learning-lab-cell
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12132 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed201,380 bytes of HTML; budget 500,000
| 1 | 211 |
| https://www.novartis.com/careers/early-careers/graduates | 200 | Graduates | NovartisPage checklist evidence- title: passedGraduates | Novartis
- description: passedAt Novartis we believe learning is a lifelong endeavour. Here you’ll find the support and the resources you need to spark your curiosity, to be inspired and to continue to learn and grow in whatever direction your career takes you.
- canonical: passedhttps://www.novartis.com/careers/early-careers/graduates
- h1: passed1 H1 element(s)
- headings: failed3 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 20 buttons have no HTML name
- links-named: passed0 of 418 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/early-careers/graduates
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedGraduates
- og-description: passedAt Novartis we believe learning is a lifelong endeavour. Here you’ll find the support and the resources you need to spark your curiosity, to be inspired and to continue to learn and grow in whatever direction your career takes you.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/early-careers/graduates
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed30220 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed272,341 bytes of HTML; budget 500,000
| 1 | 233 |
| https://www.novartis.com/careers/early-careers/students | 200 | Students | NovartisPage checklist evidence- title: passedStudents | Novartis
- description: passedExperience the world of Novartis internships. A transformative journey where you'll acquire invaluable skills from top-tier experts within a diverse and nurturing environment.
- canonical: passedhttps://www.novartis.com/careers/early-careers/students
- h1: passed1 H1 element(s)
- headings: failed4 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 19 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 19 buttons have no HTML name
- links-named: passed0 of 391 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/early-careers/students
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedStudents
- og-description: passedExperience the world of Novartis internships. A transformative journey where you'll acquire invaluable skills from top-tier experts within a diverse and nurturing environment.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/early-careers/students
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed24142 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed254,696 bytes of HTML; budget 500,000
| 1 | 234 |
| https://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs | 200 | US Biomedical Research internship programs | NovartisPage checklist evidence- title: passedUS Biomedical Research internship programs | Novartis
- description: passedThe Novartis Institutes for BioMedical Research (NIBR) give students the opportunity to gain real-world disease research experience at a global biotech company.
- canonical: passedhttps://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 353 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedUS Biomedical Research internship programs
- og-description: passedThe Novartis Institutes for BioMedical Research (NIBR) give students the opportunity to gain real-world disease research experience at a global biotech company.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/early-careers/us-biomedical-research-internship-programs
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed23473 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed214,896 bytes of HTML; budget 500,000
| 1 | 209 |
| https://www.novartis.com/careers/our-business-functions | 200 | Our business functions | NovartisPage checklist evidence- title: passedOur business functions | Novartis
- description: passedOur business functions
- canonical: passedhttps://www.novartis.com/careers/our-business-functions
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 351 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/our-business-functions
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedOur business functions | Novartis
- og-description: passedOur business functions
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/our-business-functions
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10202 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,495 bytes of HTML; budget 500,000
| 1 | 164 |
| https://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales | 200 | Careers in commercial and sales | NovartisPage checklist evidence- title: passedCareers in commercial and sales | Novartis
- description: passedTogether, we can reach more patients than ever
- canonical: passedhttps://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 351 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareers in commercial and sales | Novartis
- og-description: passedTogether, we can reach more patients than ever
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/our-business-functions/careers-commercial-and-sales
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10502 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed204,064 bytes of HTML; budget 500,000
| 1 | 174 |
| https://www.novartis.com/careers/our-business-functions/careers-global-functions | 200 | Careers in global functions | NovartisPage checklist evidence- title: passedCareers in global functions | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/careers/our-business-functions/careers-global-functions
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 352 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/our-business-functions/careers-global-functions
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareers in global functions
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/our-business-functions/careers-global-functions
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10911 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed206,302 bytes of HTML; budget 500,000
| 1 | 232 |
| https://www.novartis.com/careers/our-business-functions/careers-operations | 200 | Careers in operations | NovartisPage checklist evidence- title: passedCareers in operations | Novartis
- description: failedNo meta description
- canonical: passedhttps://www.novartis.com/careers/our-business-functions/careers-operations
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 351 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/our-business-functions/careers-operations
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareers in operations
- og-description: failedNo og:description
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/our-business-functions/careers-operations
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10664 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,957 bytes of HTML; budget 500,000
| 1 | 216 |
| https://www.novartis.com/careers/our-business-functions/careers-research-and-development | 200 | Careers in research and development | NovartisPage checklist evidence- title: passedCareers in research and development | Novartis
- description: passedLearn more about careers in Research & Development at Novartis
- canonical: passedhttps://www.novartis.com/careers/our-business-functions/careers-research-and-development
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 18 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 349 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/our-business-functions/careers-research-and-development
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCareers in research and development
- og-description: passedLearn more about careers in Research & Development at Novartis
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/our-business-functions/careers-research-and-development
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed10101 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed201,678 bytes of HTML; budget 500,000
| 1 | 252 |
| https://www.novartis.com/careers/why-novartis | 200 | Why Novartis | NovartisPage checklist evidence- title: passedWhy Novartis | Novartis
- description: passedEmpowering each other to create a better future for patients
- canonical: passedhttps://www.novartis.com/careers/why-novartis
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 33 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: passed0 of 355 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/careers/why-novartis
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedWhy Novartis | Novartis
- og-description: passedEmpowering each other to create a better future for patients
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/careers/why-novartis
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11850 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed236,199 bytes of HTML; budget 500,000
| 1 | 210 |
| https://www.novartis.com/ch-de/ | 200 | Novartis SchweizPage checklist evidence- title: passedNovartis Schweiz
- description: passedNovartis ist ein globales pharmazeutisches Unternehmen mit Hauptsitz in der Schweiz. Wir entwickeln innovative Medikamente und Therapien, um die sich stets weiterentwickelnden Bedürfnisse von Patientinnen und Patienten weltweit zu erfüllen.
- canonical: passedhttps://www.novartis.com/ch-de/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedde
- alt: passed0 of 23 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 257 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ch-de/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis ist ein globales pharmazeutisches Unternehmen mit Hauptsitz in der Schweiz. Wir entwickeln innovative Medikamente und Therapien, um die sich stets weiterentwickelnden Bedürfnisse von Patientinnen und Patienten weltweit zu erfüllen.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ch-de/node/29961
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed6874 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed151,162 bytes of HTML; budget 500,000
| 1 | 203 |
| https://www.novartis.com/ch-fr/ | 200 | Novartis SuissePage checklist evidence- title: passedNovartis Suisse
- description: passedNovartis est une entreprise pharmaceutique innovante. Chaque jour, nous nous efforçons de réinventer la médecine pour améliorer et prolonger la vie des individus. En 2023, nos médicaments ont été dispensés à 284 millions de patients dans le monde.
- canonical: passedhttps://www.novartis.com/ch-fr/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedfr
- alt: passed0 of 23 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 257 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ch-fr/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAccueil
- og-description: passedNovartis est une entreprise pharmaceutique innovante. Chaque jour, nous nous efforçons de réinventer la médecine pour améliorer et prolonger la vie des individus. En 2023, nos médicaments ont été dispensés à 284 millions de patients dans le monde.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ch-fr/node/29961
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed7035 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed152,784 bytes of HTML; budget 500,000
| 1 | 197 |
| https://www.novartis.com/clinicaltrials | 200 | Clinical trials | NovartisPage checklist evidence- title: passedClinical trials | Novartis
- description: passedClinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about clinical trials at Novartis, including opportunities to get involved.
- canonical: passedhttps://www.novartis.com/clinicaltrials
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 22 images lack an alt attribute
- labels: failed2 of 6 controls have no HTML label
- buttons: passed0 of 14 buttons have no HTML name
- links-named: passed0 of 355 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/clinicaltrials
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedClinical trials | Novartis
- og-description: passedClinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about clinical trials at Novartis, including opportunities to get involved.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/clinicaltrials
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11539 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed216,548 bytes of HTML; budget 500,000
| 1 | 186 |
| https://www.novartis.com/co-es/ | 200 | Novartis ColombiaPage checklist evidence- title: passedNovartis Colombia
- description: passedEn Novartis, estamos reimaginando la medicina
- canonical: passedhttps://www.novartis.com/co-es/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedes
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 12 buttons have no HTML name
- links-named: passed0 of 199 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/co-es/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedInicio
- og-description: passedEn Novartis, estamos reimaginando la medicina Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/co-es/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5540 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed115,189 bytes of HTML; budget 500,000
| 1 | 198 |
| https://www.novartis.com/contacts | 200 | Contacts | NovartisPage checklist evidence- title: passedContacts | Novartis
- description: passedWhether you are a customer, job seeker, health or media professional, or an investor, find relevant contact information at Novartis for your specific inquiry.
- canonical: passedhttps://www.novartis.com/contacts
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/contacts
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedContacts
- og-description: passedWhether you are a customer, job seeker, health or media professional, or an investor, find relevant contact information at Novartis for your specific inquiry.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/contacts
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed8864 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed193,926 bytes of HTML; budget 500,000
| 1 | 182 |
| https://www.novartis.com/cz-cs/ | 200 | Novartis CZPage checklist evidence- title: passedNovartis CZ
- description: passedV Novartisu přetváříme medicínu
- canonical: passedhttps://www.novartis.com/cz-cs/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedcs
- alt: passed0 of 27 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 219 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/cz-cs/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedDomů
- og-description: passedV Novartisu přetváříme medicínu Jsme globální farmaceutickou společností, která působí ve 140 zemích světa a zaměstnává přibližně 110 tisíc lidí. Naším posláním je objevovat nová řešení, které zlepšují a prodlužují život pacientů. V České republice přinášíme t
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/cz-cs/domu
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5692 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed147,138 bytes of HTML; budget 500,000
| 1 | 180 |
| https://www.novartis.com/cz-en/ | 200 | Novartis CZPage checklist evidence- title: passedNovartis CZ
- description: passedAt Novartis, we are reimagining medicine
- canonical: passedhttps://www.novartis.com/cz-en/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 27 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 219 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/cz-en/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedAt Novartis, we are reimagining medicine Jsme globální farmaceutickou společností, která působí ve 140 zemích světa a zaměstnává přibližně 110 tisíc lidí. Naším posláním je objevovat nová řešení, které zlepšují a prodlužují život pacientů. V České republice př
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/cz-en/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed5437 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed145,882 bytes of HTML; budget 500,000
| 1 | 172 |
| https://www.novartis.com/de-de/ | 200 | Novartis DeutschlandPage checklist evidence- title: passedNovartis Deutschland
- description: passedNovartis Deutschland ist ein weltweit tätiger Konzern mit starkem Patienten- und Kundenfokus. Wir konzentrieren uns auf innovative, verschreibungspflichtige Medikamente.
- canonical: passedhttps://www.novartis.com/de-de/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedde
- alt: passed0 of 28 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 15 buttons have no HTML name
- links-named: failed1 of 269 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/de-de/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedWillkommen auf den Seiten der Novartis Deutschland GmbH. Novartis Deutschland ist ein weltweit tätiger Konzern mit starkem Patienten- und Kundenfokus. Wir konzentrieren uns auf innovative, verschreibungspflichtige Medikamente und Generika.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/de-de/
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed9270 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed195,789 bytes of HTML; budget 500,000
| 1 | 212 |
| https://www.novartis.com/diseases | 200 | Diseases | NovartisPage checklist evidence- title: passedDiseases | Novartis
- description: passedFrom the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
- canonical: passedhttps://www.novartis.com/diseases
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 368 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/diseases
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedDiseases | Novartis
- og-description: passedFrom the inception of a therapeutic through early clinical development, our disease area teams collaborate across scientific disciplines and organizations in support of our mission to improve and extend peoples’ lives.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/diseases
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed14988 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed227,066 bytes of HTML; budget 500,000
| 1 | 225 |
| https://www.novartis.com/diseases/chagas-disease | 200 | Chagas disease | NovartisPage checklist evidence- title: passedChagas disease | Novartis
- description: passedChagas disease begins with a bite by the triatomine bug and can result in serious heart problems. Less than 1% of affected individuals receive proper treatment, and current tools to fight the disease are outdated and inadequate.
- canonical: passedhttps://www.novartis.com/diseases/chagas-disease
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 15 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 354 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/diseases/chagas-disease
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedChagas disease
- og-description: passedChagas disease begins with a bite by the triatomine bug and can result in serious heart problems. Less than 1% of affected individuals receive proper treatment, and current tools to fight the disease are outdated and inadequate.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/diseases/chagas-disease
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed12757 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed200,434 bytes of HTML; budget 500,000
| 1 | 193 |
| https://www.novartis.com/diseases/leprosy | 200 | Leprosy | NovartisPage checklist evidence- title: passedLeprosy | Novartis
- description: passedThe fight against leprosy is one of the greatest public health successes in history. Yet, still today, 2 to 3 million people are living with physical disability and stigma as a result of the disease.
- canonical: passedhttps://www.novartis.com/diseases/leprosy
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 15 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 357 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/diseases/leprosy
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedLeprosy
- og-description: passedThe fight against leprosy is one of the greatest public health successes in history. Yet, still today, 2 to 3 million people are living with physical disability and stigma as a result of the disease.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/diseases/leprosy
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11378 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed205,007 bytes of HTML; budget 500,000
| 1 | 176 |
| https://www.novartis.com/diseases/malaria | 200 | Malaria | NovartisPage checklist evidence- title: passedMalaria | Novartis
- description: passedSee how Novartis is working with NGOs and governments to develop the next generation of antimalarial treatments and to eradicate malaria.
- canonical: passedhttps://www.novartis.com/diseases/malaria
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 348 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/diseases/malaria
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedMalaria
- og-description: passedSee how Novartis is working with NGOs and governments to develop the next generation of antimalarial treatments and to eradicate malaria.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/diseases/malaria
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed13770 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed217,134 bytes of HTML; budget 500,000
| 1 | 218 |
| https://www.novartis.com/diseases/sickle-cell-disease | 200 | Sickle cell disease | NovartisPage checklist evidence- title: passedSickle cell disease | Novartis
- description: passedThis page gives a home to all sickle cell disease content
- canonical: passedhttps://www.novartis.com/diseases/sickle-cell-disease
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 369 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/diseases/sickle-cell-disease
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedSickle cell disease
- og-description: passedThis page gives a home to all sickle cell disease content
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/diseases/sickle-cell-disease
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed17822 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed213,538 bytes of HTML; budget 500,000
| 1 | 218 |
| https://www.novartis.com/dk-da/ | 200 | Novartis DanmarkPage checklist evidence- title: passedNovartis Danmark
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/dk-da/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedda
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 12 buttons have no HTML name
- links-named: passed0 of 186 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/dk-da/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHjem
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/dk-da/hjem
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4821 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed106,397 bytes of HTML; budget 500,000
| 1 | 205 |
| https://www.novartis.com/ee-et/ | 200 | Novartis EstoniaPage checklist evidence- title: passedNovartis Estonia
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/ee-et/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedet
- alt: passed0 of 20 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: failed1 of 209 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/ee-et/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAvaleht
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/ee-et/avaleht
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4995 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed115,930 bytes of HTML; budget 500,000
| 1 | 193 |
| https://www.novartis.com/eg-en/ | 200 | Novartis EgyptPage checklist evidence- title: passedNovartis Egypt
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/eg-en/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 21 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 207 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/eg-en/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of pati
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/eg-en/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed4989 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed120,769 bytes of HTML; budget 500,000
| 1 | 520 |
| https://www.novartis.com/es-es/ | 200 | Novartis EspañaPage checklist evidence- title: passedNovartis España
- description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- canonical: passedhttps://www.novartis.com/es-es/
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passedes
- alt: passed0 of 24 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 14 buttons have no HTML name
- links-named: failed1 of 249 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/es-es/
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedHome
- og-description: passedNovartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/es-es/home
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed7200 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed166,738 bytes of HTML; budget 500,000
| 1 | 204 |
| https://www.novartis.com/esg | 200 | ESG | NovartisPage checklist evidence- title: passedESG | Novartis
- description: passedAs a global company, we have a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
- canonical: passedhttps://www.novartis.com/esg
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 28 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 373 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/esg
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedESG | Novartis
- og-description: passedAs a global company, we have a great responsibility and an even greater opportunity to lead the world in creating a positive social change, embracing societal impact as a core business objective.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/esg
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed14747 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed229,633 bytes of HTML; budget 500,000
| 1 | 204 |
| https://www.novartis.com/esg/access | 200 | Access | NovartisPage checklist evidence- title: passedAccess | Novartis
- description: passedNovartis aims to reimagine access to healthcare through programs that help patients worldwide get the medicines they need at affordable prices.
- canonical: passedhttps://www.novartis.com/esg/access
- h1: passed1 H1 element(s)
- headings: failed1 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 23 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 350 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/esg/access
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedAccess | Novartis
- og-description: passedNovartis aims to reimagine access to healthcare through programs that help patients worldwide get the medicines they need at affordable prices.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/esg/access
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11074 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed208,666 bytes of HTML; budget 500,000
| 1 | 178 |
| https://www.novartis.com/esg/access/creating-sustainable-business-models | 200 | Creating sustainable business models | NovartisPage checklist evidence- title: passedCreating sustainable business models | Novartis
- description: passedWe believe scalable, self-sustaining social business approaches have the potential to better address global public health needs. Novartis has pioneered social business models like Healthy Family and Novartis Access.
- canonical: passedhttps://www.novartis.com/esg/access/creating-sustainable-business-models
- h1: passed1 H1 element(s)
- headings: passed0 skipped heading level(s)
- main: failed0 main landmarks
- lang: passeden
- alt: passed0 of 14 images lack an alt attribute
- labels: passed0 of 2 controls have no HTML label
- buttons: passed0 of 13 buttons have no HTML name
- links-named: passed0 of 347 links have no HTML name
- viewport: passedwidth=device-width, initial-scale=1, shrink-to-fit=no
- https: passedhttps://www.novartis.com/esg/access/creating-sustainable-business-models
- mixed: passed0 HTTP embedded resource URL(s)
- og-title: passedCreating sustainable business models
- og-description: passedWe believe scalable, self-sustaining social business approaches have the potential to better address global public health needs. Novartis has pioneered social business models like Healthy Family and Novartis Access.
- og-type: passedWebsite
- og-url: passedhttps://www.novartis.com/esg/access/creating-sustainable-business-models
- og-image: passedhttps://www.novartis.com/sites/novartis_com/files/2023-11/novartis-animated-logo-1x.gif
- og-alt: passedNovartis logo
- twitter-card: passedsummary_large_image
- readable: passed11054 characters of crawler-visible content (minimum 100)
- jsonld: passed1 of 1 blocks have valid JSON-LD structure
- html-size: passed203,641 bytes of HTML; budget 500,000
| 1 | 229 |